Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to improve healthy aging and prolong lifespan.

Unity Biotechnology designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and designs senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected.

Senisca is a biotech start-up. They propose to create a new generation of oligonucleotide-based interventions to rewind the clock in old cells and target diseases and cosmetic signs of aging. They provide molecular and cellular biology and have patent-protected an innovation for the reversal of cellular senescence.

Developer of gene editing drugs designed to meet unmet medical needs. The company focuses on the research and development of innovative gene editing drugs and is rapidly advancing in vivo gene editing tools and related delivery systems, providing clients with curative gene editing-based solutions for genetic diseases.

Rather than being a jack-of-all trades. We put all of our focus into traffic & conversion. Until we mastered the art of online customer-getting. This is what we do.  This is what we love. And this is what excites the hell out of us. We run killer campaigns that: Outperform The Competition …Almost Every Single Time ...Without Needing To Spend More On Ads! Yes, it’s a pretty big claim to make.  But we are ruthless. We don’t stop tweaking and improving campaigns until we find the winners …to give a massive boost in sales to our clients. This is what sets us apart from the others.

reverSASP Therapeutics creates innovative new drugs for aging-related diseases targeting senescent cells. With its deep understanding of underlining biology of aging-related diseases, it focuses on Senescence-associated secretory phenotype, or SASP, as a drug target.

Developer of longevity drugs designed to reverse aging and age-related diseases. The company's drugs induce the body to heal itself by instructing specific cells to fight disease or repair damaged tissue, enabling doctors to reprogram cells and combat disease.

Starkage Therapeutics is a discovery-stage biotechnology company. They also provide treatment for idiopathic pulmonary fibrosis, neurodegenerative diseases, and metabolic dysfunction or hepatic fibroses.

Seneque works to find new biochemical pathways that deliver solutions and real progress. Their clinical research approach to supporting new technologies can increase lifespan by twenty percent. They are conducting a clinical research program evaluating the effects of nicotinamide mononucleotide and other synergistic molecules in humans.

Rubedo Life Sciences is a biopharmaceutical company that is developing a diverse portfolio of innovative therapies that are engineered to target cells that are responsible for chronic age-related diseases. Its proprietary ALEMBIC drug discovery platform has generated novel first-in-class small molecules designed to selectively target senescent cells, which are important in the progression of pulmonary, dermatological, oncological, neurodegenerative, fibrotic, and other chronic diseases. The Rubedo leadership team is made up of industry leaders and pioneers in chemistry, technology, and life sciences, with extensive experience in drug development and commercialization ranging from large pharma to biotech innovators.